These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20678934)

  • 1. Introduction of guanidinium-modified deoxyuridine into the substrate binding regions of DNAzyme 10-23 to enhance target affinity: implications for DNAzyme design.
    Lam CH; Perrin DM
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5119-22. PubMed ID: 20678934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-site selection for the 10-23 DNAzyme.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile endoribonuclease mimic made of DNA: characteristics and applications of the 8-17 RNA-cleaving DNAzyme.
    Schlosser K; Li Y
    Chembiochem; 2010 May; 11(7):866-79. PubMed ID: 20213779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications.
    Ali MM; Aguirre SD; Mok WW; Li Y
    Methods Mol Biol; 2012; 848():395-418. PubMed ID: 22315083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the function of nucleotides in the catalytic cores of the 8-17 and 10-23 DNAzymes by abasic nucleotide and C3 spacer substitutions.
    Wang B; Cao L; Chiuman W; Li Y; Xi Z
    Biochemistry; 2010 Sep; 49(35):7553-62. PubMed ID: 20698496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An allosteric DNAzyme with dual RNA-cleaving and DNA-cleaving activities.
    Jiang D; Xu J; Sheng Y; Sun Y; Zhang J
    FEBS J; 2010 Jun; 277(11):2543-9. PubMed ID: 20553490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
    Lam JC; Withers JB; Li Y
    J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of a RNA-cleaving DNA catalyst obtained via in vitro selection.
    Carrigan MA; Ricardo A; Ang DN; Benner SA
    Biochemistry; 2004 Sep; 43(36):11446-59. PubMed ID: 15350131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two DNAzymes targeting the telomerase mRNA with large difference in Mg2+ concentration for maximal catalytic activity.
    Yuan BF; Xue Y; Luo M; Hao YH; Tan Z
    Int J Biochem Cell Biol; 2007; 39(6):1119-29. PubMed ID: 17499543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting insulin-like growth factor I with 10-23 DNAzymes: 2'-O-methyl modifications in the catalytic core enhance mRNA cleavage.
    Fokina AA; Meschaninova MI; Durfort T; Venyaminova AG; François JC
    Biochemistry; 2012 Mar; 51(11):2181-91. PubMed ID: 22352843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-inspired modified DNAzymes: dramatic effects of shortening side-chain length of 8-imidazolyl modified deoxyadenosines in selecting RNaseA mimicking DNAzymes.
    Hipolito CJ; Hollenstein M; Lam CH; Perrin DM
    Org Biomol Chem; 2011 Apr; 9(7):2266-73. PubMed ID: 21311779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mode of regulation of an RNA-cleaving DNAzyme by effectors that bind to both enzyme and substrate.
    Wang DY; Sen D
    J Mol Biol; 2001 Jul; 310(4):723-34. PubMed ID: 11453683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position-specific modification with imidazolyl group on10-23 DNAzyme realized catalytic activity enhancement.
    Li Z; Liu Y; Liu G; Zhu J; Zheng Z; Zhou Y; He J
    Bioorg Med Chem; 2014 Aug; 22(15):4010-7. PubMed ID: 24961875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new and efficient DNA enzyme for the sequence-specific cleavage of RNA.
    Feldman AR; Sen D
    J Mol Biol; 2001 Oct; 313(2):283-94. PubMed ID: 11800557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid sequence analysis using DNAzymes.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():291-302. PubMed ID: 15017058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.
    Vester B; Hansen LH; Lundberg LB; Babu BR; Sørensen MD; Wengel J; Douthwaite S
    BMC Mol Biol; 2006 Jun; 7():19. PubMed ID: 16753066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of platelet-type 12-lipoxygenase activity in human erythroleukemia cells by an RNA-cleaving DNAzyme.
    Liu C; Cheng R; Sun LQ; Tien P
    Biochem Biophys Res Commun; 2001 Jun; 284(4):1077-82. PubMed ID: 11409904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes.
    Wang DY; Lai BH; Sen D
    J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaining target access for deoxyribozymes.
    Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
    J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion analysis in the catalytic region of the 10-23 DNA enzyme.
    Zaborowska Z; Schubert S; Kurreck J; Erdmann VA
    FEBS Lett; 2005 Jan; 579(2):554-8. PubMed ID: 15642375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.